Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
From the *Molecular Immunopharmacology and Drug Discovery Laboratory, Departments of Molecular Physiology and Pharmacology, †Internal Medicine, ‡Psychiatry, §Biochemistry, and ∥Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine and Tufts Medical Center, Boston, MA.Journal of clinical psychopharmacology (Impact Factor: 5.09). 06/2011; 31(4):403-5. DOI: 10.1097/JCP.0b013e318225848c
- Journal of clinical psychopharmacology 02/2014; · 5.09 Impact Factor
- Journal of clinical psychopharmacology 12/2011; 31(6):685-7. · 5.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.